Clinical trial
Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia: a Double-blind, Randomized, Placebo-controlled Trial
NCT06624696 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia: a Double-blind, Randomized, Placebo-controlled Trial
- Lead sponsor
- Sun Yat-sen University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 12, 2024
- Completion date
- August 18, 2026
- Enrollment
- 204 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
anticholinergics, high risk, inhalation therapy; complications, perioperative respiratory adverse events, respiratory hypersensitivity